ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In 90-95% of cases with CML, the BCR/ABL fusion gene is the result of reciprocal translocation between chromosomes 9 and 22 and is cytogenetically observable as a small derivative chromosome 22 which is known as Philadelphia (Ph1) chromosome [1,2].